KP Tissue Inc. (TSE:KPT – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$12.38 and traded as low as C$11.79. KP Tissue shares last traded at C$11.79, with a volume of 14,010 shares.
Analyst Upgrades and Downgrades
Separately, TD dropped their price target on KP Tissue from C$14.00 to C$13.00 and set a “hold” rating for the company in a research note on Wednesday, October 14th. Three equities research analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of C$11.88.
View Our Latest Stock Report on KP Tissue
KP Tissue Stock Performance
The stock has a market capitalization of C$116.97 million, a P/E ratio of 13.25, a price-to-earnings-growth ratio of -0.88 and a beta of 0.54. The stock’s fifty day simple moving average is C$12.43 and its two-hundred day simple moving average is C$12.38.
KP Tissue (TSE:KPT – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported C$0.24 earnings per share (EPS) for the quarter. As a group, analysts expect that KP Tissue Inc. will post 0.44 earnings per share for the current fiscal year.
KP Tissue Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 15th were paid a $0.21 dividend. The ex-dividend date of this dividend was Tuesday, September 29th. This represents a $0.84 annualized dividend and a dividend yield of 7.2%. KP Tissue’s payout ratio is currently 85.23%.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Read More
- Five stocks we like better than KP Tissue
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
